• Home
• Contact Us
• About Budapest
• About ISAC 2008
• Accommodation
• Awards
• Commercial Exhibition
• Committees
• General Information
• Introductory Courses
• Itinerary Builder
• Key Dates
• Program
• Registration
• Submissions
• Social Activities
• Sponsorship
• Student Information
• Tours
• Travel Awards
• Travel and Visas
• Volunteer Opportunities

Keynote Address

D. Lansing Taylor, Ph.D.

President and CEO

Cellumen, Inc.

D. Lansing Taylor, Ph.D. is the founder, President and CEO of Cellumen, the Systems Cell Biology company. Cellumen offers products and services to accelerate the successful progression of candidate therapeutics from the discovery laboratory through the clinic. Before founding Cellumen, Dr. Taylor was the founder, Chairman, President and CEO of Cellomics, Inc., the company that created High Content Screening, from 1996 until 2004.

Cellomics was sold to Fisher Scientific in 2005. Dr. Taylor previously co-founded, with Alan Waggoner, Biological Detection Systems, Inc. (BDS). BDS developed, patented and commercialized the multi-color, fluorescent, cyanine dyes that have become a standard in fluorescence detection.  BDS was sold to Amersham Biosciences, now GE Healthcare in 1996.  He is also the Chairman of the Board of Directors of the Pittsburgh Life Sciences Greenhouse, a member of the Board of Celsense, Inc. and NetHealth, Inc.  Dr. Taylor is on the external advisory committee for the Mayo Clinic and Foundation Cancer Center.  Dr. Taylor is the author of more than 20 patents and over 150 scientific papers. Dr. Taylor was an academic researcher before entering the biotechnology industry.  He was a Professor of Biological Sciences, Vice-Dean of Molecular Sciences, and Director of the National Science Foundation, Science and Technology Center at Carnegie Mellon University from 1982-1996.  Dr. Taylor started his academic career as a Professor at Harvard University. 

Title of Keynote Lecture:

Evolution of Imaging Cytometry: The Integration of Biology, Reagents, Instrumentation, Application Software and Informatics.

The lecture will be a review of some of the most important developments in the field of cell analysis coupled with a view to the future of imaging cytometry.  The critical role of the integration of instrumentation, application software, reagents, cell biology and informatics will be stressed.